(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
 . . . . . . . . . .



11th Edition of The International Pharmacopoeia is now published [1]

[]

Date: 2023-11-03  

The International Pharmacopoeia is a collection of recommended procedures for analysis and specifications for active pharmaceutical ingredients, excipients and finished pharmaceutical products. It serves WHO Member States wishing to establish pharmaceutical requirements as source material for reference or adaptation.



The International Pharmacopoeia focuses on monographs of particular relevance to low- and middle-income countries which may not have sufficient resources to develop national pharmacopoeias. Our compendium supports key WHO activities, such as the Organization's efforts to make essential medicines available and affordable for everyone, everywhere and to combat substandard and falsified medicines.



Numerous new and revised texts have been introduced in the 11th Edition, including for example:

Albendazole chewable tablets

Dolutegravir (dispersible) tablets

Dolutegravir, lamivudine and tenofovir disoproxil tablets

Lamivudine oral solutions

Norethisterone enantate injection

Remdesivir intravenous infusion

Tenofovir disoproxil fumarate

Ulipristal acetate tablets





To access the 11th Edition of The International Pharmacopoeia click here.

[END]
---
[1] Url: https://www.who.int/news/item/02-03-2023-11th-edition-of-the-international-pharmacopoeia-is-now-published

Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/